Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function

NCT00972374 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00972374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00972374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
July 31, 2011
Enrollment
44 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rhegmatogenous macula-off retinal detachment